Victory Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Victory Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,072	Closed	-$248K	–	2783
2022 Q1	$248K	Sell	14,072 -746	-5%	-$13.4K	﹤0.01%	2362
2021 Q4	$317K	Buy	14,818 +3,531	+31%	+$69.6K	﹤0.01%	2362
2021 Q3	$209K	Sell	11,287 -558	-5%	-$11.2K	﹤0.01%	2515
2021 Q2	$254K	Sell	11,845 -1,078	-8%	-$21.9K	﹤0.01%	2471
2021 Q1	$249K	Buy	+12,923	New	+$228K	﹤0.01%	2464

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Victory Capital Management's OCDX Position: Q2 2022 in Review

Victory Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 14,072 shares — an estimated $248K sold.

Victory Capital Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $317K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Victory Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Victory Capital Management sold 14,072 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $248K.
Victory Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Victory Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $317K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.